Rayonier Advanced Materials (RYAM) Financials

$3.90 -0.03 (-0.64%)

Closing price 05/23/2025 03:59 PM Eastern

Extended Trading

$3.90 -0.01 (-0.26%)

As of 05/23/2025 07:13 PM Eastern

Annual Income Statements for Rayonier Advanced Materials

This table shows Rayonier Advanced Materials' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Net Income / (Loss) Attributable to Common Shareholders	-39	-102	-15
Consolidated Net Income / (Loss)	-39	-102	-15
Net Income / (Loss) Continuing Operations	-42	-102	-27
Total Pre-Tax Income	-49	-132	-24
Total Operating Income	39	-65	26
Total Gross Profit	166	88	123
Total Revenue	1,630	1,643	1,717
Operating Revenue	1,630	1,643	1,717
Total Cost of Revenue	1,465	1,555	1,594
Operating Cost of Revenue	1,465	1,555	1,594
Total Operating Expenses	126	153	97
Selling, General & Admin Expense	92	76	91
Other Operating Expenses / (Income)	-7.96	15	5.47
Impairment Charge	25	62	0.00
Restructuring Charge	17	0.00	0.00
Total Other Income / (Expense), net	-89	-67	-50
Interest Expense	86	73	66
Other Income / (Expense), net	-2.97	6.14	16
Income Tax Expense	-8.93	-32	0.90
Other Gains / (Losses), net	-1.65	-1.98	-2.65
Net Income / (Loss) Discontinued Operations	3.22	0.31	12
Net Income / (Loss) Attributable to Noncontrolling Interest	0.04	0.00	0.00
Basic Earnings per Share	($0.59)	($1.57)	($0.23)
Weighted Average Basic Shares Outstanding	65.97M	65.40M	64.20M
Diluted Earnings per Share	($0.59)	($1.57)	($0.23)
Weighted Average Diluted Shares Outstanding	65.97M	65.40M	64.20M
Weighted Average Basic & Diluted Shares Outstanding	65.97M	65.40M	64.20M

This table shows Rayonier Advanced Materials' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/28/2024	6/29/2024	3/30/2024	12/31/2023	9/30/2023	7/1/2023	4/1/2023	12/31/2022	9/24/2022
Net Income / (Loss) Attributable to Common Shareholders	-16	-33	11	-1.57	-62	-25	-17	1.61	3.59	30
Consolidated Net Income / (Loss)	-16	-33	11	-1.57	-62	-25	-17	1.61	3.59	30
Net Income / (Loss) Continuing Operations	-16	-33	8.17	-1.57	-62	-27	-16	1.61	3.59	18
Total Pre-Tax Income	-19	-37	7.78	-1.59	-82	-32	-18	-0.33	1.79	17
Total Operating Income	11	-17	28	17	-61	-14	-6.46	17	16	29
Total Gross Profit	37	44	48	37	27	8.73	15	37	44	47
Total Revenue	423	401	419	388	422	369	385	467	500	466
Operating Revenue	423	401	419	388	422	369	385	467	500	466
Total Cost of Revenue	386	358	371	351	395	360	371	429	456	420
Operating Cost of Revenue	386	358	371	351	395	360	371	429	456	420
Total Operating Expenses	26	60	20	20	88	23	21	21	28	18
Selling, General & Admin Expense	27	23	22	21	17	21	18	19	23	20
Other Operating Expenses / (Income)	-2.93	4.69	-8.32	-1.39	8.86	2.01	3.09	1.35	4.19	-1.89
Total Other Income / (Expense), net	-30	-20	-20	-19	-21	-17	-12	-17	-15	-11
Interest Expense	23	20	21	21	22	21	15	15	17	16
Other Income / (Expense), net	-6.61	0.61	0.85	2.19	0.08	3.78	3.71	-1.43	2.36	5.13
Income Tax Expense	-3.01	-4.60	-0.85	-0.47	-21	-5.39	-3.25	-2.59	-2.33	-1.82
Other Gains / (Losses), net	-0.23	-0.52	-0.45	-0.45	-0.39	-0.26	-0.68	-0.65	-0.53	-0.69
Basic Earnings per Share	($0.25)	($0.49)	$0.17	($0.02)	($0.94)	($0.39)	($0.26)	$0.02	$0.05	$0.47
Weighted Average Basic Shares Outstanding	65.97M	65.92M	65.89M	65.58M	65.40M	65.34M	65.34M	65.12M	64.20M	63.97M
Diluted Earnings per Share	($0.25)	($0.49)	$0.17	($0.02)	($0.94)	($0.39)	($0.26)	$0.02	$0.07	$0.45
Weighted Average Diluted Shares Outstanding	65.97M	65.92M	65.89M	65.58M	65.40M	65.34M	65.34M	65.12M	64.20M	63.97M
Weighted Average Basic & Diluted Shares Outstanding	65.97M	65.92M	65.89M	65.58M	65.40M	65.34M	65.34M	65.12M	64.20M	63.97M

This table details how cash moves in and out of Rayonier Advanced Materials' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Net Change in Cash & Equivalents	53	-78	-98
Net Cash From Operating Activities	204	136	69
Net Cash From Continuing Operating Activities	204	136	69
Net Income / (Loss) Continuing Operations	-42	-102	-27
Consolidated Net Income / (Loss)	-39	-102	-15
Net Income / (Loss) Discontinued Operations	3.22	0.31	12
Depreciation Expense	137	140	135
Amortization Expense	8.56	6.05	4.03
Non-Cash Adjustments To Reconcile Net Income	67	63	-18
Changes in Operating Assets and Liabilities, net	33	30	-24
Net Cash From Investing Activities	-108	-127	-94
Net Cash From Continuing Investing Activities	-108	-128	-139
Purchase of Property, Plant & Equipment	-108	-128	-138
Acquisitions	0.00	-0.78	-0.38
Net Cash From Discontinued Investing Activities	0.00	1.17	44
Net Cash From Financing Activities	-42	-87	-73
Net Cash From Continuing Financing Activities	-42	-87	-73
Repayment of Debt	-728	-547	-78
Repurchase of Common Equity	-1.19	0.00	0.00
Issuance of Debt	672	465	5.72
Issuance of Common Equity	16	0.00	0.00
Other Financing Activities, net	-0.91	-5.42	-0.43
Cash Interest Paid	95	51	58
Cash Income Taxes Paid	-19	7.24	-15

This table details how cash moves in and out of Rayonier Advanced Materials' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/28/2024	6/29/2024	3/30/2024	12/31/2023	9/30/2023	7/1/2023	4/1/2023	12/31/2022	9/24/2022
Net Change in Cash & Equivalents	-5.86	19	60	-20	47	-129	-13	16	15	-12
Net Cash From Operating Activities	55	50	88	11	54	-1.72	32	51	61	44
Net Cash From Continuing Operating Activities	55	50	88	11	54	-1.72	32	51	61	44
Net Income / (Loss) Continuing Operations	-16	-33	8.17	-1.57	-62	-27	-16	1.61	3.59	18
Consolidated Net Income / (Loss)	-16	-33	11	-1.57	-62	-25	-17	1.61	3.59	30
Depreciation Expense	35	35	34	33	36	36	32	35	38	35
Non-Cash Adjustments To Reconcile Net Income	30	31	4.75	1.43	59	3.47	-0.28	0.13	-22	-0.55
Changes in Operating Assets and Liabilities, net	-2.95	16	41	-22	15	-15	16	14	38	-9.22
Net Cash From Investing Activities	-28	-22	-25	-33	-32	-41	-33	-21	-24	-26
Net Cash From Continuing Investing Activities	-28	-22	-25	-33	-33	-41	-33	-21	-24	-28
Purchase of Property, Plant & Equipment	-28	-22	-25	-33	-32	-41	-33	-21	-24	-28
Net Cash From Financing Activities	-33	-8.87	-2.03	0.93	25	-86	-12	-14	-22	-29
Net Cash From Continuing Financing Activities	-33	-8.87	-2.03	0.93	25	-86	-12	-14	-22	-29
Repayment of Debt	-487	-19	-93	-130	-139	-387	-12	-8.37	-22	-31
Issuance of Debt	440	10	91	131	164	301	0.14	-0.11	-	1.87
Other Financing Activities, net	-0.25	-0.02	-0.19	-0.45	-0.06	-	-0.25	-5.11	-0.13	0.00
Cash Interest Paid	24	27	9.76	34	0.71	22	9.56	19	9.67	19
Cash Income Taxes Paid	0.61	-15	-3.17	-1.59	0.02	0.13	4.06	3.03	1.28	-23

This table presents Rayonier Advanced Materials' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Total Assets	2,130	2,183	2,348
Total Current Assets	601	575	690
Cash & Equivalents	125	76	152
Accounts Receivable	214	197	212
Inventories, net	208	207	265
Prepaid Expenses	51	75	60
Current Deferred & Refundable Income Taxes	2.64	19	1.20
Plant, Property, & Equipment, net	1,019	1,075	1,151
Total Noncurrent Assets	510	533	507
Intangible Assets	10	17	24
Noncurrent Deferred & Refundable Income Taxes	350	345	322
Other Noncurrent Operating Assets	150	170	160
Total Liabilities & Shareholders' Equity	2,130	2,183	2,348
Total Liabilities	1,405	1,436	1,518
Total Current Liabilities	400	376	354
Short-Term Debt	23	25	15
Accounts Payable	196	186	164
Accrued Expenses	181	164	175
Total Noncurrent Liabilities	1,005	1,060	1,165
Long-Term Debt	706	752	839
Asset Retirement Reserve & Litigation Obligation	160	160	160
Noncurrent Deferred & Payable Income Tax Liabilities	14	15	17
Noncurrent Employee Benefit Liabilities	77	101	120
Other Noncurrent Operating Liabilities	47	31	29
Commitments & Contingencies	0.00	0.00	0.00
Redeemable Noncontrolling Interest	11	0.00	-
Total Equity & Noncontrolling Interests	714	746	829
Total Preferred & Common Equity	714	746	829
Total Common Equity	714	746	829
Common Stock	426	420	419
Retained Earnings	334	373	474
Accumulated Other Comprehensive Income / (Loss)	-46	-46	-64

This table presents Rayonier Advanced Materials' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	9/28/2024	6/29/2024	3/30/2024	9/30/2023	7/1/2023	4/1/2023	9/24/2022
Total Assets	2,159	2,197	2,135	2,176	2,306	2,310	2,336
Total Current Assets	629	635	546	518	640	662	688
Cash & Equivalents	136	114	55	27	157	169	132
Accounts Receivable	193	204	183	176	177	201	217
Inventories, net	234	225	228	243	219	237	270
Prepaid Expenses	63	74	61	73	86	54	69
Current Deferred & Refundable Income Taxes	2.77	17	19	-	-	-	1.05
Plant, Property, & Equipment, net	1,022	1,057	1,058	1,132	1,152	1,144	1,132
Total Noncurrent Assets	509	505	532	525	515	504	516
Intangible Assets	12	14	16	19	21	23	26
Noncurrent Deferred & Refundable Income Taxes	348	343	345	329	327	324	328
Other Noncurrent Operating Assets	148	148	171	177	167	157	162
Total Liabilities & Shareholders' Equity	2,159	2,197	2,135	2,176	2,306	2,310	2,336
Total Liabilities	1,427	1,442	1,393	1,390	1,492	1,479	1,557
Total Current Liabilities	364	377	332	334	410	321	341
Short-Term Debt	26	25	23	19	82	14	22
Accounts Payable	167	186	158	171	179	158	154
Accrued Expenses	171	166	152	144	149	149	165
Total Noncurrent Liabilities	1,063	1,065	1,061	1,056	1,082	1,158	1,216
Long-Term Debt	748	753	756	730	753	831	851
Asset Retirement Reserve & Litigation Obligation	160	160	160	159	159	159	159
Noncurrent Deferred & Payable Income Tax Liabilities	15	14	14	15	19	19	17
Noncurrent Employee Benefit Liabilities	94	95	99	120	121	118	159
Other Noncurrent Operating Liabilities	46	44	31	32	30	29	30
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	733	755	742	786	814	831	780
Total Preferred & Common Equity	733	755	742	786	814	831	780
Total Common Equity	733	755	742	786	814	831	780
Common Stock	424	423	421	419	417	415	418
Retained Earnings	350	382	371	434	459	476	471
Accumulated Other Comprehensive Income / (Loss)	-41	-50	-50	-67	-62	-60	-109

This table displays calculated financial ratios and metrics derived from Rayonier Advanced Materials' official financial filings.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Growth Metrics	-	-	-
Revenue Growth	-0.79%	-4.31%	22.00%
EBITDA Growth	109.70%	-51.98%	44.06%
EBIT Growth	161.76%	-239.57%	357.08%
NOPAT Growth	160.49%	-349.72%	350.22%
Net Income Growth	61.99%	-582.59%	-122.46%
EPS Growth	62.42%	-582.61%	-121.90%
Operating Cash Flow Growth	49.41%	98.04%	-70.49%
Free Cash Flow Firm Growth	298.71%	160.25%	-333.66%
Invested Capital Growth	-8.23%	-5.39%	5.47%
Revenue Q/Q Growth	0.00%	-4.50%	7.93%
EBITDA Q/Q Growth	66.44%	-46.61%	26.70%
EBIT Q/Q Growth	228.57%	-389.63%	344.59%
NOPAT Q/Q Growth	221.52%	-644.18%	702.74%
Net Income Q/Q Growth	54.12%	-177.85%	64.93%
EPS Q/Q Growth	53.91%	-180.36%	64.06%
Operating Cash Flow Q/Q Growth	0.39%	-5.04%	103.75%
Free Cash Flow Firm Q/Q Growth	27.63%	72.18%	41.94%
Invested Capital Q/Q Growth	-2.98%	-3.95%	0.66%
Profitability Metrics	-	-	-
Gross Margin	10.16%	5.36%	7.17%
EBITDA Margin	11.18%	5.29%	10.54%
Operating Margin	2.42%	-3.97%	1.52%
EBIT Margin	2.24%	-3.60%	2.47%
Profit (Net Income) Margin	-2.37%	-6.20%	-0.87%
Tax Burden Percent	78.67%	76.87%	62.63%
Interest Burden Percent	-134.74%	224.07%	-56.24%
Effective Tax Rate	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	1.99%	-3.07%	1.23%
ROIC Less NNEP Spread (ROIC-NNEP)	-8.17%	-11.07%	-3.74%
Return on Net Nonoperating Assets (RNNOA)	-7.25%	-9.86%	-3.04%
Return on Equity (ROE)	-5.26%	-12.93%	-1.82%
Cash Return on Invested Capital (CROIC)	10.57%	2.47%	-4.10%
Operating Return on Assets (OROA)	1.69%	-2.61%	1.77%
Return on Assets (ROA)	-1.80%	-4.50%	-0.62%
Return on Common Equity (ROCE)	-5.23%	-12.93%	-1.82%
Return on Equity Simple (ROE_SIMPLE)	-5.42%	-13.64%	-1.80%
Net Operating Profit after Tax (NOPAT)	28	-46	18
NOPAT Margin	1.70%	-2.78%	1.07%
Net Nonoperating Expense Percent (NNEP)	10.16%	8.00%	4.96%
Return On Investment Capital (ROIC_SIMPLE)	1.91%	-3.00%	1.09%
Cost of Revenue to Revenue	89.84%	94.64%	92.83%
SG&A Expenses to Revenue	5.66%	4.61%	5.33%
R&D to Revenue	0.00%	0.00%	0.00%
Operating Expenses to Revenue	7.73%	9.33%	5.65%
Earnings before Interest and Taxes (EBIT)	37	-59	42
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	182	87	181
Valuation Ratios	-	-	-
Price to Book Value (P/BV)	0.76	0.35	0.74
Price to Tangible Book Value (P/TBV)	0.77	0.36	0.76
Price to Revenue (P/Rev)	0.33	0.16	0.36
Price to Earnings (P/E)	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.87	0.67	0.86
Enterprise Value to Revenue (EV/Rev)	0.71	0.59	0.77
Enterprise Value to EBITDA (EV/EBITDA)	6.36	11.12	7.27
Enterprise Value to EBIT (EV/EBIT)	31.74	0.00	31.05
Enterprise Value to NOPAT (EV/NOPAT)	41.93	0.00	71.90
Enterprise Value to Operating Cash Flow (EV/OCF)	5.69	7.09	19.12
Enterprise Value to Free Cash Flow (EV/FCFF)	7.90	26.25	0.00
Leverage & Solvency	-	-	-
Debt to Equity	1.01	1.04	1.03
Long-Term Debt to Equity	0.98	1.01	1.01
Financial Leverage	0.89	0.89	0.81
Leverage Ratio	2.93	2.87	2.92
Compound Leverage Factor	-3.95	6.44	-1.64
Debt to Total Capital	50.19%	51.02%	50.71%
Short-Term Debt to Total Capital	1.61%	1.66%	0.87%
Long-Term Debt to Total Capital	48.58%	49.36%	49.84%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.72%	0.00%	0.00%
Common Equity to Total Capital	49.09%	48.98%	49.29%
Debt to EBITDA	4.00	8.95	4.71
Net Debt to EBITDA	3.32	8.07	3.88
Long-Term Debt to EBITDA	3.88	8.65	4.63
Debt to NOPAT	26.41	-17.02	46.63
Net Debt to NOPAT	21.88	-15.36	38.34
Long-Term Debt to NOPAT	25.56	-16.46	45.83
Altman Z-Score	1.39	1.12	1.49
Noncontrolling Interest Sharing Ratio	0.71%	0.00%	0.00%
Liquidity Ratios	-	-	-
Current Ratio	1.50	1.53	1.95
Quick Ratio	0.85	0.73	1.03
Cash Flow Metrics	-	-	-
Free Cash Flow to Firm (FCFF)	147	37	-61
Operating Cash Flow to CapEx	188.63%	106.74%	49.78%
Free Cash Flow to Firm to Interest Expense	1.71	0.50	-0.92
Operating Cash Flow to Interest Expense	2.38	1.86	1.04
Operating Cash Flow Less CapEx to Interest Expense	1.12	0.12	-1.05
Efficiency Ratios	-	-	-
Asset Turnover	0.76	0.73	0.72
Accounts Receivable Turnover	7.93	8.04	8.74
Inventory Turnover	7.05	6.58	6.43
Fixed Asset Turnover	1.56	1.48	1.49
Accounts Payable Turnover	7.66	8.88	9.56
Days Sales Outstanding (DSO)	46.06	45.42	41.78
Days Inventory Outstanding (DIO)	51.77	55.48	56.78
Days Payable Outstanding (DPO)	47.66	41.09	38.17
Cash Conversion Cycle (CCC)	50.17	59.81	60.39
Capital & Investment Metrics	-	-	-
Invested Capital	1,329	1,448	1,531
Invested Capital Turnover	1.17	1.10	1.15
Increase / (Decrease) in Invested Capital	-119	-82	79
Enterprise Value (EV)	1,159	966	1,315
Market Capitalization	544	265	614
Book Value per Share	$10.83	$11.42	$12.96
Tangible Book Value per Share	$10.67	$11.16	$12.58
Total Capital	1,454	1,524	1,682
Total Debt	730	777	853
Total Long-Term Debt	706	752	839
Net Debt	605	702	701
Capital Expenditures (CapEx)	108	128	138
Debt-free, Cash-free Net Working Capital (DFCFNWC)	99	149	199
Debt-free Net Working Capital (DFNWC)	224	225	350
Net Working Capital (NWC)	201	199	336
Net Nonoperating Expense (NNE)	66	56	33
Net Nonoperating Obligations (NNO)	605	702	701
Total Depreciation and Amortization (D&A)	146	146	139
Debt-free, Cash-free Net Working Capital to Revenue	6.07%	9.05%	11.57%
Debt-free Net Working Capital to Revenue	13.75%	13.66%	20.41%
Net Working Capital to Revenue	12.32%	12.12%	19.56%
Earnings Adjustments	-	-	-
Adjusted Basic Earnings per Share	($0.59)	($1.57)	($0.23)
Adjusted Weighted Average Basic Shares Outstanding	65.97M	65.40M	64.20M
Adjusted Diluted Earnings per Share	($0.59)	($1.57)	($0.23)
Adjusted Weighted Average Diluted Shares Outstanding	65.97M	65.40M	64.20M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	65.97M	65.40M	64.20M
Normalized Net Operating Profit after Tax (NOPAT)	57	-2.07	18
Normalized NOPAT Margin	3.49%	-0.13%	1.07%
Pre Tax Income Margin	-3.02%	-8.06%	-1.39%
Debt Service Ratios	-	-	-
EBIT to Interest Expense	0.43	-0.81	0.64
NOPAT to Interest Expense	0.32	-0.62	0.28
EBIT Less CapEx to Interest Expense	-0.83	-2.54	-1.45
NOPAT Less CapEx to Interest Expense	-0.94	-2.36	-1.81
Payout Ratios	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%
Augmented Payout Ratio	-3.08%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from Rayonier Advanced Materials' official financial filings.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/28/2024	6/29/2024	3/30/2024	12/31/2023	9/30/2023	7/1/2023	4/1/2023	12/31/2022	9/24/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	0.00%	8.80%	8.73%	-16.95%	-15.50%	-20.95%	-3.46%	32.71%	33.74%	24.69%
EBITDA Growth	258.50%	-26.13%	110.75%	4.21%	-143.86%	-62.61%	-1.71%	140.13%	149.32%	106.36%
EBIT Growth	107.22%	-51.90%	1,156.18%	27.03%	-426.35%	-131.67%	22.62%	337.15%	231.58%	1,620.79%
NOPAT Growth	118.06%	-16.34%	792.07%	2.90%	-213.83%	-132.04%	-122.85%	205.08%	477.78%	1,494.91%
Net Income Growth	74.14%	-29.87%	168.00%	-197.70%	-1,814.70%	-184.78%	28.01%	106.47%	114.95%	722.26%
EPS Growth	73.40%	-25.64%	165.38%	-200.00%	-1,442.86%	-186.67%	27.78%	105.13%	120.59%	742.86%
Operating Cash Flow Growth	1.45%	2,995.53%	169.76%	-78.08%	-11.78%	-103.94%	354.44%	318.49%	133.11%	113.53%
Free Cash Flow Firm Growth	218.52%	4,277.69%	361.52%	618.78%	195.03%	104.07%	122.66%	-107.54%	-278.05%	-125.38%
Invested Capital Growth	-8.23%	-9.14%	-4.88%	-2.78%	-5.39%	-0.85%	-1.78%	1.48%	5.47%	7.21%
Revenue Q/Q Growth	5.34%	-4.28%	8.10%	-8.24%	14.60%	-4.34%	-17.43%	-6.65%	7.21%	16.81%
EBITDA Q/Q Growth	108.27%	-69.62%	19.05%	313.52%	-197.07%	-13.33%	-41.13%	-11.44%	-17.25%	127.85%
EBIT Q/Q Growth	127.15%	-155.74%	50.77%	131.83%	-471.22%	-287.56%	-118.13%	-18.70%	-44.57%	1,046.96%
NOPAT Q/Q Growth	165.53%	-137.60%	161.67%	128.01%	-322.17%	-123.67%	-138.91%	-69.01%	18.82%	1,655.82%
Net Income Q/Q Growth	51.14%	-386.20%	825.48%	97.45%	-145.39%	-49.85%	-1,142.31%	-55.26%	-87.87%	227.25%
EPS Q/Q Growth	48.98%	-388.24%	950.00%	97.87%	-141.03%	-50.00%	-1,400.00%	-71.43%	-84.44%	225.00%
Operating Cash Flow Q/Q Growth	10.21%	-43.11%	677.57%	-79.19%	3,245.55%	-105.30%	-36.81%	-16.26%	40.33%	442.66%
Free Cash Flow Firm Q/Q Growth	0.69%	21.12%	93.00%	35.33%	1,283.79%	-87.23%	316.94%	75.21%	40.68%	28.95%
Invested Capital Q/Q Growth	-2.98%	-3.44%	-3.21%	1.22%	-3.95%	1.08%	-1.08%	-1.49%	0.66%	0.14%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	8.74%	10.86%	11.53%	9.48%	6.47%	2.37%	3.80%	8.02%	8.78%	9.98%
EBITDA Margin	9.37%	4.74%	14.93%	13.56%	-5.91%	6.98%	7.70%	10.80%	11.39%	14.75%
Operating Margin	2.61%	-4.19%	6.73%	4.40%	-14.43%	-3.92%	-1.68%	3.56%	3.26%	6.12%
EBIT Margin	1.04%	-4.04%	6.93%	4.97%	-14.41%	-2.89%	-0.71%	3.25%	3.73%	7.22%
Profit (Net Income) Margin	-3.77%	-8.13%	2.72%	-0.41%	-14.58%	-6.81%	-4.35%	0.34%	0.72%	6.35%
Tax Burden Percent	85.11%	88.90%	146.50%	98.74%	74.85%	79.25%	92.09%	-486.97%	200.67%	171.91%
Interest Burden Percent	-425.85%	226.49%	26.77%	-8.25%	135.15%	297.18%	661.38%	-2.18%	9.60%	51.17%
Effective Tax Rate	0.00%	0.00%	-10.92%	0.00%	0.00%	0.00%	0.00%	0.00%	-130.06%	-10.59%
Return on Invested Capital (ROIC)	2.14%	-3.32%	8.20%	3.24%	-11.14%	-3.12%	-1.42%	3.05%	8.64%	7.33%
ROIC Less NNEP Spread (ROIC-NNEP)	-1.48%	-6.39%	5.23%	1.31%	-13.84%	-5.17%	-3.12%	1.59%	3.57%	7.04%
Return on Net Nonoperating Assets (RNNOA)	-1.31%	-5.72%	4.47%	1.17%	-12.32%	-4.83%	-2.84%	1.35%	2.91%	6.18%
Return on Equity (ROE)	0.83%	-9.04%	12.67%	4.41%	-23.47%	-7.94%	-4.26%	4.40%	11.54%	13.51%
Cash Return on Invested Capital (CROIC)	10.57%	7.99%	3.55%	-0.23%	2.47%	1.41%	79.28%	1.27%	-4.10%	-7.16%
Operating Return on Assets (OROA)	0.79%	-3.04%	4.92%	3.50%	-10.45%	-2.21%	-0.55%	2.51%	2.67%	4.77%
Return on Assets (ROA)	-2.85%	-6.11%	1.93%	-0.29%	-10.58%	-5.19%	-3.37%	0.27%	0.51%	4.20%
Return on Common Equity (ROCE)	0.82%	-9.04%	12.67%	4.41%	-23.47%	-7.94%	-4.26%	4.40%	11.54%	13.51%
Return on Equity Simple (ROE_SIMPLE)	0.00%	-11.51%	-10.18%	-14.16%	0.00%	-4.66%	2.22%	1.39%	0.00%	-5.46%
Net Operating Profit after Tax (NOPAT)	7.71	-12	31	12	-43	-10	-4.52	12	37	32
NOPAT Margin	1.82%	-2.93%	7.46%	3.08%	-10.10%	-2.74%	-1.17%	2.49%	7.50%	6.77%
Net Nonoperating Expense Percent (NNEP)	3.62%	3.07%	2.97%	1.93%	2.70%	2.05%	1.70%	1.46%	5.07%	0.28%
Return On Investment Capital (ROIC_SIMPLE)	0.53%	-	-	-	-2.80%	-	-	-	2.23%	-
Cost of Revenue to Revenue	91.26%	89.14%	88.47%	90.52%	93.53%	97.63%	96.20%	91.98%	91.22%	90.02%
SG&A Expenses to Revenue	6.32%	5.66%	5.20%	5.44%	4.04%	5.74%	4.67%	4.18%	4.69%	4.27%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	6.14%	15.05%	4.80%	5.08%	20.88%	6.29%	5.47%	4.47%	5.53%	3.86%
Earnings before Interest and Taxes (EBIT)	4.40	-16	29	19	-61	-11	-2.75	15	19	34
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	40	19	63	53	-25	26	30	50	57	69
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.76	0.76	0.47	0.42	0.35	0.29	0.34	0.48	0.74	0.30
Price to Tangible Book Value (P/TBV)	0.77	0.78	0.48	0.43	0.36	0.30	0.35	0.50	0.76	0.32
Price to Revenue (P/Rev)	0.33	0.34	0.22	0.20	0.16	0.13	0.15	0.22	0.36	0.15
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	15.44	34.88	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	6.48%	2.87%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.87	0.87	0.72	0.71	0.67	0.63	0.64	0.72	0.86	0.64
Enterprise Value to Revenue (EV/Rev)	0.71	0.73	0.64	0.66	0.59	0.55	0.53	0.59	0.77	0.61
Enterprise Value to EBITDA (EV/EBITDA)	6.36	10.93	8.78	12.44	11.12	5.86	4.65	5.23	7.27	6.85
Enterprise Value to EBIT (EV/EBIT)	31.74	0.00	0.00	0.00	0.00	46.70	14.77	16.88	31.05	102.67
Enterprise Value to NOPAT (EV/NOPAT)	41.93	0.00	0.00	0.00	0.00	113.55	0.82	26.34	71.90	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	5.69	5.90	6.75	10.78	7.09	6.64	5.06	7.51	19.12	28.96
Enterprise Value to Free Cash Flow (EV/FCFF)	7.90	10.41	19.75	0.00	26.25	44.58	0.80	56.90	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	1.01	1.06	1.03	1.05	1.04	0.95	1.03	1.02	1.03	1.12
Long-Term Debt to Equity	0.98	1.02	1.00	1.02	1.01	0.93	0.92	1.00	1.01	1.09
Financial Leverage	0.89	0.90	0.85	0.89	0.89	0.93	0.91	0.85	0.81	0.88
Leverage Ratio	2.93	2.86	2.87	2.83	2.87	2.88	2.98	2.93	2.92	3.07
Compound Leverage Factor	-12.49	6.47	0.77	-0.23	3.89	8.57	19.69	-0.06	0.28	1.57
Debt to Total Capital	50.19%	51.35%	50.74%	51.21%	51.02%	48.81%	50.62%	50.43%	50.71%	52.81%
Short-Term Debt to Total Capital	1.61%	1.70%	1.63%	1.52%	1.66%	1.21%	4.95%	0.85%	0.87%	1.30%
Long-Term Debt to Total Capital	48.58%	49.65%	49.11%	49.70%	49.36%	47.59%	45.67%	49.57%	49.84%	51.50%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.72%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	49.09%	48.65%	49.26%	48.79%	48.98%	51.19%	49.38%	49.57%	49.29%	47.19%
Debt to EBITDA	4.00	7.06	6.69	9.34	8.95	4.60	4.05	4.10	4.71	6.11
Net Debt to EBITDA	3.32	5.82	5.71	8.69	8.07	4.44	3.29	3.28	3.88	5.19
Long-Term Debt to EBITDA	3.88	6.83	6.48	9.07	8.65	4.49	3.66	4.03	4.63	5.96
Debt to NOPAT	26.41	-34.00	-36.88	-17.17	-17.02	89.23	0.72	20.65	46.63	-287.48
Net Debt to NOPAT	21.88	-28.02	-31.46	-15.97	-15.36	86.00	0.58	16.51	38.34	-244.10
Long-Term Debt to NOPAT	25.56	-32.88	-35.69	-16.66	-16.46	87.01	0.65	20.30	45.83	-280.38
Altman Z-Score	1.34	1.34	1.30	1.26	1.12	1.26	1.29	1.44	1.46	1.28
Noncontrolling Interest Sharing Ratio	0.71%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.50	1.73	1.69	1.64	1.53	1.55	1.56	2.06	1.95	2.02
Quick Ratio	0.85	0.91	0.84	0.71	0.73	0.61	0.81	1.16	1.03	1.03
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	127	126	104	54	40	2.88	23	-10	-42	-71
Operating Cash Flow to CapEx	194.21%	230.22%	344.06%	34.60%	166.74%	-4.19%	98.47%	242.63%	255.01%	158.61%
Free Cash Flow to Firm to Interest Expense	5.49	6.15	4.89	2.58	1.85	0.14	1.46	-0.67	-2.49	-4.30
Operating Cash Flow to Interest Expense	2.38	2.43	4.12	0.54	2.52	-0.08	2.10	3.32	3.64	2.66
Operating Cash Flow Less CapEx to Interest Expense	1.15	1.38	2.92	-1.02	1.01	-2.04	-0.03	1.95	2.21	0.98
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.76	0.75	0.71	0.70	0.73	0.76	0.78	0.77	0.72	0.66
Accounts Receivable Turnover	7.93	8.83	8.39	8.14	8.04	8.75	9.44	9.10	8.74	7.55
Inventory Turnover	7.05	6.19	6.64	6.35	6.58	6.31	7.26	7.28	6.43	6.30
Fixed Asset Turnover	1.56	1.51	1.45	1.42	1.48	1.52	1.57	1.58	1.49	1.40
Accounts Payable Turnover	7.66	8.72	8.08	9.37	8.88	9.93	9.22	9.56	9.56	10.06
Days Sales Outstanding (DSO)	46.06	41.32	43.52	44.84	45.42	41.70	38.68	40.11	41.78	48.32
Days Inventory Outstanding (DIO)	51.77	59.01	54.97	57.52	55.48	57.84	50.31	50.11	56.78	57.91
Days Payable Outstanding (DPO)	47.66	41.87	45.17	38.96	41.09	36.75	39.57	38.18	38.17	36.28
Cash Conversion Cycle (CCC)	50.17	58.46	53.31	63.40	59.81	62.79	49.42	52.05	60.39	69.95
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,329	1,370	1,419	1,466	1,448	1,508	1,491	1,508	1,531	1,521
Invested Capital Turnover	1.17	1.13	1.10	1.05	1.10	1.14	1.21	1.22	1.15	1.08
Increase / (Decrease) in Invested Capital	-119	-138	-73	-42	-82	-13	-27	22	79	102
Enterprise Value (EV)	1,159	1,197	1,020	1,037	966	953	956	1,079	1,315	978
Market Capitalization	544	560	357	313	265	231	279	403	614	237
Book Value per Share	$10.83	$11.12	$11.52	$11.34	$11.42	$12.02	$12.50	$12.95	$12.96	$12.19
Tangible Book Value per Share	$10.67	$10.94	$11.30	$11.10	$11.16	$11.73	$12.18	$12.60	$12.58	$11.78
Total Capital	1,454	1,506	1,533	1,520	1,524	1,535	1,648	1,677	1,682	1,652
Total Debt	730	773	778	779	777	749	834	846	853	873
Total Long-Term Debt	706	748	753	756	752	730	753	831	839	851
Net Debt	605	637	664	724	702	722	677	676	701	741
Capital Expenditures (CapEx)	28	22	25	33	32	41	33	21	24	28
Debt-free, Cash-free Net Working Capital (DFCFNWC)	99	155	169	182	149	175	154	186	199	238
Debt-free Net Working Capital (DFNWC)	224	291	283	236	225	203	311	356	350	369
Net Working Capital (NWC)	201	265	258	213	199	184	229	341	336	348
Net Nonoperating Expense (NNE)	24	21	20	14	19	15	12	10	34	1.94
Net Nonoperating Obligations (NNO)	605	637	664	724	702	722	677	676	701	741
Total Depreciation and Amortization (D&A)	35	35	34	33	36	36	32	35	38	35
Debt-free, Cash-free Net Working Capital to Revenue	6.07%	9.49%	10.59%	11.60%	9.05%	10.19%	8.46%	10.16%	11.57%	14.93%
Debt-free Net Working Capital to Revenue	13.75%	17.83%	17.73%	15.10%	13.66%	11.77%	17.09%	19.41%	20.41%	23.21%
Net Working Capital to Revenue	12.32%	16.26%	16.17%	13.62%	12.12%	10.69%	12.61%	18.63%	19.56%	21.85%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.25)	($0.49)	$0.17	($0.02)	($0.94)	($0.39)	($0.26)	$0.02	$0.05	$0.47
Adjusted Weighted Average Basic Shares Outstanding	65.97M	65.92M	65.89M	65.58M	65.40M	65.34M	65.34M	65.12M	64.20M	63.97M
Adjusted Diluted Earnings per Share	($0.25)	($0.49)	$0.17	($0.02)	($0.94)	($0.39)	($0.26)	$0.02	$0.07	$0.45
Adjusted Weighted Average Diluted Shares Outstanding	65.97M	65.92M	65.89M	65.58M	65.40M	65.34M	65.34M	65.12M	64.20M	63.97M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	65.97M	65.92M	65.89M	65.58M	65.40M	65.34M	65.34M	65.12M	64.20M	63.97M
Normalized Net Operating Profit after Tax (NOPAT)	7.71	11	24	12	-43	-10	-4.52	12	11	20
Normalized NOPAT Margin	1.82%	2.83%	5.82%	3.08%	-10.10%	-2.74%	-1.17%	2.49%	2.28%	4.28%
Pre Tax Income Margin	-4.43%	-9.14%	1.86%	-0.41%	-19.48%	-8.59%	-4.72%	-0.07%	0.36%	3.69%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.19	-0.79	1.37	0.92	-2.83	-0.51	-0.18	0.98	1.11	2.05
NOPAT to Interest Expense	0.33	-0.57	1.47	0.57	-1.98	-0.48	-0.29	0.75	2.22	1.92
EBIT Less CapEx to Interest Expense	-1.03	-1.85	0.17	-0.64	-4.34	-2.46	-2.31	-0.39	-0.32	0.37
NOPAT Less CapEx to Interest Expense	-0.89	-1.63	0.27	-0.99	-3.49	-2.43	-2.43	-0.62	0.80	0.24
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	-3.08%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions About Rayonier Advanced Materials' Financials

When does Rayonier Advanced Materials's fiscal year end?

According to the most recent income statement we have on file, Rayonier Advanced Materials' financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Rayonier Advanced Materials' net income changed over the last 2 years?

Rayonier Advanced Materials' net income appears to be on an upward trend, with a most recent value of -$38.71 million in 2024, rising from -$14.92 million in 2022. The previous period was -$101.84 million in 2023. See Rayonier Advanced Materials' forecast for analyst expectations on what’s next for the company.

What is Rayonier Advanced Materials's operating income?

Rayonier Advanced Materials's total operating income in 2024 was $39.48 million, based on the following breakdown:

Total Gross Profit: $165.58 million
Total Operating Expenses: $126.10 million

How has Rayonier Advanced Materials revenue changed over the last 2 years?

Over the last 2 years, Rayonier Advanced Materials' total revenue changed from $1.72 billion in 2022 to $1.63 billion in 2024, a change of -5.1%.

How much debt does Rayonier Advanced Materials have?

Rayonier Advanced Materials' total liabilities were at $1.41 billion at the end of 2024, a 2.2% decrease from 2023, and a 7.4% decrease since 2022.

How much cash does Rayonier Advanced Materials have?

In the past 2 years, Rayonier Advanced Materials' cash and equivalents has ranged from $75.77 million in 2023 to $151.80 million in 2022, and is currently $125.22 million as of their latest financial filing in 2024.

How has Rayonier Advanced Materials' book value per share changed over the last 2 years?

Over the last 2 years, Rayonier Advanced Materials' book value per share changed from 12.96 in 2022 to 10.83 in 2024, a change of -16.5%.

Related Companies

This page (NYSE:RYAM) was last updated on 5/25/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Rayonier Advanced Materials (RYAM) Financials

Frequently Asked Questions About Rayonier Advanced Materials' Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Rayonier Advanced Materials (RYAM) Financials

Annual Income Statements for Rayonier Advanced Materials

Quarterly Income Statements for Rayonier Advanced Materials

Annual Cash Flow Statements for Rayonier Advanced Materials

Quarterly Cash Flow Statements for Rayonier Advanced Materials

Annual Balance Sheets for Rayonier Advanced Materials

Quarterly Balance Sheets for Rayonier Advanced Materials

Annual Metrics And Ratios for Rayonier Advanced Materials

Quarterly Metrics And Ratios for Rayonier Advanced Materials

Frequently Asked Questions About Rayonier Advanced Materials' Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools